← back to search

Chen Wang

Xiamen University · CN
Area of research
Reproductive Medicine · Cancer Research
Research interest
Research interests include Ovarian cancer diagnosis and treatment, Cancer Genomics and Diagnostics, Ferroptosis and cancer prognosis, and Cancer-related molecular mechanisms research.
h-index
55
citations
19,512
works
642
NIH funding
primary concept
Medicine
email

Recent publications

Ultraprocessed Food Consumption and Risk of Early-Onset Colorectal Cancer Precursors Among Women
JAMA Oncology 2025cited by 14position: firstdoi
Caffeic Acid Acts as a Potent Senomorphic and Alleviates Inflammation and Lung Fibrosis by Covalently Targeting Annexin A5 Protein in Mice
Exploration 2025cited by 5position: middledoi
NALCN expression is down-regulated and associated with immune infiltration in gastric cancer
Frontiers in Immunology 2025cited by 2position: middledoi
Stroke and myocardial infarction induce neutrophil extracellular trap release disrupting lymphoid organ structure and immunoglobulin secretion
Nature Cardiovascular Research 2024cited by 41position: middledoi
Concurrent RB1 Loss and <i>BRCA</i> Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma
Clinical Cancer Research 2024cited by 12position: middledoi
1649P Impact of concomitant medications on safety in patients with high-volume metastatic hormone-sensitive prostate cancer (mHSPC) receiving rezvilutamide (Rez) plus androgen-deprivation therapy (ADT): A post-hoc analysis of the randomized phase III CHART trial
Annals of Oncology 2024cited by 0position: middledoi
Single-cell RNA sequencing deciphers the mechanism of sepsis-induced liver injury and the therapeutic effects of artesunate
Acta Pharmacologica Sinica 2023cited by 38position: middledoi
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study
The Journal of Pathology Clinical Research 2023cited by 26position: middledoi
Enabling the clinical application of artificial intelligence in genomics: a perspective of the AMIA Genomics and Translational Bioinformatics Workgroup
Journal of the American Medical Informatics Association 2023cited by 14position: middledoi
Concurrent RB1 loss and <i>BRCA</i> -deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma
medRxiv 2023cited by 5position: middledoi
The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer
Nature Genetics 2022cited by 109position: middledoi
Extrachromosomal Circular DNA (eccDNA): From Chaos to Function
Frontiers in Cell and Developmental Biology 2022cited by 58position: middledoi
Combined lifestyle, mental health, and mortality in US cancer survivors: a national cohort study
Journal of Translational Medicine 2022cited by 32position: middledoi
Pyrroloquinoline quinone modulates YAP-related anti-ferroptotic activity to protect against myocardial hypertrophy
Frontiers in Pharmacology 2022cited by 10position: middledoi
Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Their Variations as a Basis for a Prediction Model in Advanced NSCLC Patients Receiving Anlotinib
Disease Markers 2022cited by 9position: middledoi
MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin 2021cited by 23position: middledoi
Proteomic Analysis of Emodin Treatment in Neuropathic Pain Reveals Dysfunction of the Calcium Signaling Pathway
Journal of Pain Research 2021cited by 16position: middledoi
Identification of Slc6a19os and SOX11 as Two Novel Essential Genes in Neuropathic Pain Using Integrated Bioinformatic Analysis and Experimental Verification
Frontiers in Neuroscience 2021cited by 13position: middledoi
Reprogramming to recover youthful epigenetic information and restore vision
Nature 2020cited by 812position: middledoi
Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)
Clinical Cancer Research 2020cited by 75position: middledoi
[Effects of different materials for partial sciatic nerve ligation on glial cell activation in rat models of chronic constriction injury].
PubMed 2020cited by 2position: firstdoi
Dilution of Molecular–Pathologic Gene Signatures by Medically Associated Factors Might Prevent Prediction of Resection Status After Debulking Surgery in Patients With Advanced Ovarian Cancer
Clinical Cancer Research 2019cited by 17position: middledoi
Genomic and Functional Approaches to Understanding Cancer Aneuploidy
Cancer Cell 2018cited by 1,182position: middledoi
Pathogenic Germline Variants in 10,389 Adult Cancers
Cell 2018cited by 879position: middledoi
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers
Cancer Cell 2018cited by 697position: middledoi
Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas
Cell Reports 2018cited by 365position: middledoi
Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study
The Journal of Pathology Clinical Research 2018cited by 98position: middledoi
A systematic review and meta-analysis: Association between MGMT hypermethylation and the clinicopathological characteristics of non-small-cell lung carcinoma
Scientific Reports 2018cited by 21position: middledoi
Dose-Response Association of CD8<sup>+</sup> Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer
JAMA Oncology 2017cited by 398position: middledoi
Challenges and Opportunities in Studying the Epidemiology of Ovarian Cancer Subtypes
Current Epidemiology Reports 2017cited by 105position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ellen L. Goode · Mayo Clinic4 papers (2013–2016)Gottfried E. Konecny · UCLA Medical Center4 papers (2013–2016)Habib Hamidi · Acentech (United States)4 papers (2013–2016)Kimberly R. Kalli · Mayo Clinic in Florida4 papers (2013–2016)Boris Winterhoff · University of Minnesota4 papers (2013–2016)Brooke L. Fridley · Children's Mercy Hospital3 papers (2013–2016)Dongsheng Lin · Guangzhou University of Chinese Medicine3 papers (2020–2021)Peng Chen · Xinjiang University2 papers (2020–2021)Jigang Wang · Qingdao University2 papers (2023–2025)Yin Kwan Wong · National University of Singapore2 papers (2023–2025)Melissa C. Larson · Roswell Park Comprehensive Cancer Center2 papers (2013–2014)Gary L. Keeney · Mayo Clinic in Arizona2 papers (2014–2016)He-Jing Wang · UCLA Jonsson Comprehensive Cancer Center2 papers (2014–2016)Jeremy Chien · University of California, Davis2 papers (2013–2014)Julie M. Cunningham · Mayo Clinic2 papers (2013–2014)Lynn C. Hartmann · Mayo Clinic2 papers (2013–2014)Jinglian Qu · Guizhou University2 papers (2021–2021)Marina Bibikova · Illumina (United States)2 papers (2013–2014)Hsiao‐Wang Chen · University of California, Los Angeles2 papers (2014–2016)Bobbie S. Gostout · Mayo Clinic2 papers (2014–2016)